Personalizing medicine through targeted agents, capitalizing on pathway dysregulation and biomarker use. (Record no. 28417920)

MARC details
000 -LEADER
fixed length control field 00717 a2200181 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517215708.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-828X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2217/17410541.5.6.575
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hirshfield, Kim Marie
245 00 - TITLE STATEMENT
Title Personalizing medicine through targeted agents, capitalizing on pathway dysregulation and biomarker use.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Personalized medicine
Date of publication, distribution, etc. Nov 2008
300 ## - PHYSICAL DESCRIPTION
Extent 575-577 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
773 0# - HOST ITEM ENTRY
Title Personalized medicine
Related parts vol. 5
-- no. 6
-- p. 575-577
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2217/17410541.5.6.575">https://doi.org/10.2217/17410541.5.6.575</a>
Public note Available from publisher's website

No items available.